Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

21 Jul 2026 12:22 PM | Anonymous member (Administrator)

Takahito Sugase MD, PhD, Takashi Kanemura MD, PhD, Norihiro Matsuura MD, PhD, Kei Yamamoto MD, PhD, Yuki Ushimaru MD, PhD, Yasunori Masuike MD, PhD, Yoshitomo Yanagimoto MD, PhD, Kazuyoshi Yamamoto MD, PhD, Yoshihiro Sakano MD, PhD, Ryota Mori MD, PhD, Masatoshi Kitakaze MD, PhD, Masahiko Kubo MD, PhD, Yasunari Fukuda MD, PhD,Hisateru Komatsu MD, PhD, Masaaki Miyo MD, PhD, Toshinori Sueda MD, PhD, Yoshinori Kagawa MD, PhD, Kunihito Gotoh MD, PhD, Shogo Kobayashi MD, PhD & Hiroshi Miyata MD, PhD

    Read Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

    Affiliated Societies



    International  Interdisciplinary  Everything Esophageal


    The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

    General Inquiries: info@isde.net
    Membership Questions: membership@isde.net

    Powered by Wild Apricot Membership Software